Adaptive designs for single-arm phase II trials in oncology

Clinical phase II trials in oncology are conducted to determine whether the activity of a new anticancer treatment is promising enough to merit further investigation. Two-stage designs are commonly used for this situation to allow for early termination. Designs proposed in the literature so far have...

Full description

Saved in:
Bibliographic Details
Main Authors: Englert, Stefan (Author) , Kieser, Meinhard (Author)
Format: Article (Journal)
Language:English
Published: May/June 2012
In: Pharmaceutical statistics
Year: 2012, Volume: 11, Issue: 3, Pages: 241-249
ISSN:1539-1612
DOI:10.1002/pst.541
Online Access:Verlag, Volltext: http://dx.doi.org/10.1002/pst.541
Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1002/pst.541
Get full text
Author Notes:Stefan Englert and Meinhard Kieser
Description
Summary:Clinical phase II trials in oncology are conducted to determine whether the activity of a new anticancer treatment is promising enough to merit further investigation. Two-stage designs are commonly used for this situation to allow for early termination. Designs proposed in the literature so far have the common drawback that the sample sizes for the two stages have to be specified in the protocol and have to be adhered to strictly during the course of the trial. As a consequence, designs that allow a higher extent of flexibility are desirable. In this article, we propose a new adaptive method that allows an arbitrary modification of the sample size of the second stage using the results of the interim analysis or external information while controlling the type I error rate. If the sample size is not changed during the trial, the proposed design shows very similar characteristics to the optimal two-stage design proposed by Chang et al. (Biometrics 1987; 43:865-874). However, the new design allows the use of mid-course information for the planning of the second stage, thus meeting practical requirements when performing clinical phase II trials in oncology. Copyright © 2012 John Wiley & Sons, Ltd.
Item Description:Gesehen am 08.11.2018
Physical Description:Online Resource
ISSN:1539-1612
DOI:10.1002/pst.541